Takashi Tokino

Prof. Takashi Tokino

Department of Medical Genome Science, Research Institute for Frontier Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 June 2003 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
MTMinoru Toyota
Minoru Toyota
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
ASAyumi Satoh
Ayumi Satoh
KOKazuhiro Ogi
Kazuhiro Ogi
TKTakefumi Kikuchi
Takefumi Kikuchi
Takashi TokinoTakashi Tokino
Takashi Tokino
Cell-cycle checkpoints controlling the orderly progression through mitosis are frequently disrupted in human cancers. One such checkpoint, entry into metaphase, is regulated by the CHFR gene encoding a protein possessing forkhead-associated and RING finger domains as well as ubiquitin–ligase activity. Although defects in this checkpoint have been described, the molecular basis and prevalence of CHFR inactivation in human tumors are still not fully understood. To address this question, we analyzed the pattern of CHFR expression in a number of human cancer cell lines and primary tumors. We found CpG methylation-dependent silencing of CHFR expression in 45% of cancer cell lines, 40% of primary colorectal cancers, 53% of colorectal adenomas, and 30% of primary head and neck cancers. Expression of CHFR was precisely correlated with both CpG methylation and deacetylation of histones H3 and H4 in the CpG-rich regulatory region. Moreover, CpG methylation and thus silencing of CHFR depended on the activities of two DNA methyltransferases, DNMT1 and DNMT3b, as their genetic inactivation restored CHFR expression. Finally, cells with CHFR methylation had an intrinsically high mitotic index when treated with microtubule inhibitor. This means that cells in which CHFR was epigenetically inactivated constitute loss-of-function alleles for mitotic checkpoint control. Taken together, these findings shed light on a pathway by which mitotic checkpoint is bypassed in cancer cells and suggest that inactivation of checkpoint genes is much more widespread than previously suspected.

1 January 2000 in Critical Reviews in Oncology/Hematology
Verified
Journal Article
Closed access
Takashi TokinoTakashi Tokino
Takashi Tokino
YNYusuke Nakamura
Yusuke Nakamura

1 April 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
LKLisa Kashima
Lisa Kashima
MIMasashi Idogawa
Masashi Idogawa
HMHiroaki Mita
Hiroaki Mita
MSMiki Shitashige
Miki Shitashige
TYTesshi Yamada
Tesshi Yamada
Takashi TokinoTakashi Tokino
Takashi Tokino
The mitotic checkpoint gene CHFR (checkpoint with forkhead-associated (FHA) and RING finger domains) is silenced by promoter hypermethylation or mutated in various human cancers, suggesting that CHFR is an important tumor suppressor. Recent studies have reported that CHFR functions as an E3 ubiquitin ligase, resulting in the degradation of target proteins. To better understand how CHFR suppresses cell cycle progression and tumorigenesis, we sought to identify CHFR-interacting proteins using affinity purification combined with mass spectrometry. Here we show poly(ADP-ribose) polymerase 1 (PARP-1) to be a novel CHFR-interacting protein. In CHFR-expressing cells, mitotic stress induced the autoPARylation of PARP-1, resulting in an enhanced interaction between CHFR and PARP-1 and an increase in the polyubiquitination/degradation of PARP-1. The decrease in PARP-1 protein levels promoted cell cycle arrest at prophase, supporting that the cells expressing CHFR were resistant to microtubule inhibitors. In contrast, in CHFR-silenced cells, polyubiquitination was not induced in response to mitotic stress. Thus, PARP-1 protein levels did not decrease, and cells progressed into mitosis under mitotic stress, suggesting that CHFR-silenced cancer cells were sensitized to microtubule inhibitors. Furthermore, we found that cells from Chfr knockout mice and CHFR-silenced primary gastric cancer tissues expressed higher levels of PARP-1 protein, strongly supporting our data that the interaction between CHFR and PARP-1 plays an important role in cell cycle regulation and cancer therapeutic strategies. On the basis of our studies, we demonstrate a significant advantage for use of combinational chemotherapy with PARP inhibitors for cancer cells resistant to microtubule inhibitors.

7 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
NTNaoki Tanimizu
Naoki Tanimizu
NINorihisa Ichinohe
Norihisa Ichinohe
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
TITohru Itoh
Tohru Itoh
RSRyo Sudo
Ryo Sudo
TMToshihiro Mitaka
Toshihiro Mitaka
In the liver, the bile canaliculi of hepatocytes are connected to intrahepatic bile ducts lined with cholangiocytes, which remove cytotoxic bile from the liver tissue. Although liver organoids have been reported, it is not clear whether the functional connection between hepatocytes and cholangiocytes is recapitulated in those organoids. Here, we report the generation of a hepatobiliary tubular organoid (HBTO) using mouse hepatocyte progenitors and cholangiocytes. Hepatocytes form the bile canalicular network and secrete metabolites into the canaliculi, which are then transported into the biliary tubular structure. Hepatocytes in HBTO acquire and maintain metabolic functions including albumin secretion and cytochrome P450 activities, over the long term. In this study, we establish functional liver tissue incorporating a bile drainage system ex vivo. HBTO enable us to reproduce the transport of hepatocyte metabolites in liver tissue, and to investigate the way in which the two types of epithelial cells establish functional connections.

27 March 2017 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
MIMasashi Idogawa
Masashi Idogawa
TOTomoko Ohashi
Tomoko Ohashi
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
HNHiroshi Nakase
Hiroshi Nakase
Takashi TokinoTakashi Tokino
Takashi Tokino

15 July 2017 in Oncotarget
Verified
Journal Article
Open access
PDF file
TNTakafumi Nakagaki
Takafumi Nakagaki
MTMiyuki Tamura
Miyuki Tamura
KKKenta Kobashi
Kenta Kobashi
RKRyota Koyama
Ryota Koyama
HFHisayo Fukushima
Hisayo Fukushima
Yasushi SasakiYasushi Sasaki
Yasushi Sasaki
Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing Profiling cancer-related gene mutations in oral squamous cell carcinoma from Japanese patients by targeted amplicon sequencing